1. Gemcitabine: metabolism, mechanisms of action, and self-potentiation;Plunkett;Semin. Oncol.,1995
2. Clinical, toxicological and pharmacologic aspects of gemcitabine;Guchelaar;Cancer Treat. Rev.,1996
3. A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer;Rajkumar;Cancer Treat. Rev.,1998
4. LY231514, a novel pyrrolopyrimidine antifolate that inhibits thymidylate synthase (TS);Grindley;Proc. Am. Assoc. Cancer Res.,1992
5. Antimetabolites;Schilsky,1992